Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Total-Backed Amyris Gets $11 Million for Research on Farnesene

Aug. 14 (Bloomberg) -- Amyris Inc., the biotechnology company partially owned by Total SA, received almost $11 million from France’s largest oil producer to continue researching the chemical compound farnesene.

The debt taken on by Emeryville, California-based Amyris came from convertible notes, Joel Velasco, a company spokesman, said today in an e-mail.

Total, Amyris’s largest shareholder, owned almost 21 percent of Amyris as of May 29, according to data compiled by Bloomberg.

Amyris deploys genetically modified microorganisms to convert plant sugars into fragrance oils or farnesene, a hydrocarbon used to make specialty chemicals or fuels.

To contact the reporter on this story: Justin Doom in New York at

To contact the editors responsible for this story: Reed Landberg at Robin Saponar

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.